Over a 4-year study period from 2015 to 2018, altogether 183 isolates of bacterial meningitis were collected from 12 hospitals covering the entire Moroccan territory. Neisseria meningitidis represented 58.5%, Streptococcus pneumoniae 35.5%, and Haemophilus influenzae type b 6%. H. influenzae type b mainly affected 5-year-olds and unvaccinated adults. N. meningitidis serogroup B represented 90.7% followed by serogroup W135 with 6.5%. Decreased susceptibility to penicillin G (DSPG) for all isolates accounted for 15.7%, with 11.6% being resistant to penicillin G (PG) and 4.1% decreased susceptibility. Cumulative results of all strains showed 2.7% decreased susceptibility to amoxicillin and 3.3% resistant, 2.2% of isolates were resistant to third-generation cephalosporin and 2.2% were decreased susceptible, 5.5% were resistant to chloramphenicol and 2.7% were resistant to rifampin. The frequency of DSPG observed in our study is more common in S. pneumoniae than in N. meningitidis (P < 0.05). These isolates have been found to be highly susceptible to antibiotics used for treatment and prophylaxis chemotherapy and the observed resistance remains rare. The impact of introduction of conjugate vaccines against H. influenzae type b and S. pneumoniae (PCVs) is an advantage in reducing meningitis cases due to these two species.
Houri H, Pormohammad A, Riahi SM, Nasiri MJ, Fallah F, Dabiri H, Acute bacterial meningitis in Iran: Systematic review and meta-analysis. PLoS One 2017; 12: e0169617. https://doi.org/10.1371/journal.pone.0169617.
Agier L, Martiny N, Thiongane O, Mueller JE, Paireau J, Watkins ER, Towards understanding the epidemiology of Neisseria meningitidis in the African meningitis belt: a multi-disciplinary overview. Int J Infect Dis 2017; 54: 103–12. https://doi.org/10.1016/j.ijid.2016.10.032.
Merabet M, Aouragh R, Idrissi A. Les méningites bactériennes aigues communautaires chez les enfants de moins de 5 ans à la région Tanger-Tétouan-Al Hoceima (Maroc) 2006-2015 : Profil épidémiologique, clinique et biologique.Community-acquired acute bacterial meningitis in children under 5. Antropo 2018; 40: 1–11.
Costerus JM, Brouwer MC, Bijlsma MW, Tanck MW, van der Ende A, van de Beek D. Impact of an evidence-based guideline on the management of community-acquired bacterial meningitis: a prospective cohort study. Clin Microbiol Infect 2016; 22: 928–33. https://doi.org/10.1016/j.cmi.2016.07.026.
Barkia A, Braikat M, Charof R, Souadiya H, El Idrissi MH, Moumni H, Guide de la lutte contre les méningites bactériennes communautaires. Guideline on the Community Bacterial Meningitis Control. MoH Moro, WHO 2010; 78: 1–78.
Ramdani-Bouguessa N, Ziane H, Bekhoucha S, Guechi Z, Azzam A, Touati D, Evolution of antimicrobial resistance and serotype distribution of Streptococcus pneumoniae isolated from children with invasive and noninvasive pneumococcal diseases in Algeria from 2005 to 2012. New Microbes New Infect 2015; 6: 42–8. https://doi.org/10.1016/j.nmni.2015.02.008.
Smaoui H, Bouafsoun A, Kechrid A. Epidemiology of bacterial meningitis in tunisian children (2000–2011). Arch Dis Child 2012; 97: A249–A249. https://doi.org/10.1136/archdischild-2012-302724.0867.
World Health Organization. Meningitis Weekly Bulletin.Weekly feedback bulletin on cerebrospinal meningitis. 2019 April 1st to 7th. 1–10 p. n.d.
van Ettekoven CN, van de Beek D, Brouwer MC. Update on community-acquired bacterial meningitis: guidance and challenges. Clin Microbiol Infect 2017; 23: 601–6. https://doi.org/10.1016/j.cmi.2017.04.019.
Kharkhal HN, Titov LP. Serogroup diversity and antibiotic susceptibility of Neisseria meningitidis: meningococcus infection monitoring in Belarus. Acta Microbiol Immunol Hung 2019; 66: 443–57.
Borrow R, Caugant DA, Ceyhan M, Christensen H, Dinleyici EC, Findlow J, Meningococcal disease in the Middle East and Africa: Findings and updates from the Global Meningococcal Initiative. J Infect 2017; 75: 1–11. https://doi.org/10.1016/j.jinf.2017.04.007.
Braikat M, Barkia A, Mdaghri N El, Rainey JJ, Cohen AL, Teleb N. Vaccination with Haemophilus influenzae type b conjugate vaccine reduces bacterial meningitis in Morocco. Vaccine 2012; 30: 2594–9. https://doi.org/10.1016/j.vaccine.2012.01.041.
Diawara I, Zerouali K, Katfy K, Zaki B, Belabbes H, Najib J, Invasive pneumococcal disease among children younger than 5 years of age before and after introduction of pneumococcal conjugate vaccine in Casablanca, Morocco. Int J Infect Dis 2015; 40: 95–101. https://doi.org/10.1016/j.ijid.2015.09.019.
de Oliveira LH, Camacho LAB, Coutinho ESF, Martinez-Silveira MS, Carvalho AF, Ruiz-Matus C, Impact and Effectiveness of 10 and 13-Valent Pneumococcal Conjugate Vaccines on Hospitalization and Mortality in Children Aged Less than 5 Years in Latin American Countries: A Systematic Review. PLoS One 2016; 11: e0166736. https://doi.org/10.1371/journal.pone.0166736.
Shah N. Impact of pneumococcal conjugate vaccines (PCV) on pneumonia, the forgotten killer of children. Pediatr Infect Dis 2016; 8: 72–5. https://doi.org/10.1016/j.pid.2016.06.001.
Ceyhan M, Ozsurekci Y, Lucidarme J, Borrow R, Gürler N, Emiroglu MK, Characterization of invasive Neisseria meningitidis isolates recovered from children in Turkey during a period of increased serogroup B disease, 2013–2017. Vaccine 2020; 38: 3545–52. https://doi.org/10.1016/j.vaccine.2020.03.024.
Parikh SR, Campbell H, Bettinger JA, Harrison LH, Marshall HS, Martinon-Torres F, The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination, J Infect 2020; 81(4): 483–498. https://doi.org/10.1016/j.jinf.2020.05.079.
Watson PS, Turner DPJ. Clinical experience with the meningococcal B vaccine, Bexsero(®): prospects for reducing the burden of meningococcal serogroup B disease. Vaccine 2016; 34: 875–80. https://doi.org/10.1016/j.vaccine.2015.11.057.
Zerouali K, Elmdaghri N, Boudouma M, Benbachir M. Serogroups, serotypes, serosubtypes and antimicrobial susceptibility of Neisseria meningitidis isolates in Casablanca, Morocco. Eur J Clin Microbiol Infect Dis 2002; 21: 483–5. https://doi.org/10.1007/s10096-002-0736-y.
El Mdaghri N, Jilali N, Belabbes H, Jouhadi Z, Lahssoune M, Zaid S. Epidemiological profile of invasive bacterial diseases in children in Casablanca, Morocco: antimicrobial susceptibilities and serotype distribution. East Mediterr Health J 2012; 18: 1097–101. https://doi.org/10.26719/2012.18.11.1097.
Ben Haj Khalifa A, Mastouri M, Ben Abdallah H, Noomen S, Kheder M. Les méningites purulentes dans la région de Monastir, Tunisie (1999–2006) : aspects bactériologiques et état de résistance aux antibiotiques. Acquired bacterial meningitis in Monastir region, Tunisia (1999–2006): bacteriological aspects and susceptibility. Bull La Soc Pathol Exot 2011; 104: 42–8. https://doi.org/10.1007/s13149-010-0077-5.
Saguer A, Smaoui H, Taha M-K, Kechrid A. Characterization of invasive Neisseria meningitidis strains isolated at the Children’s Hospital of Tunis, Tunisia. East Mediterr Health J 2016; 22: 343–9. https://doi.org/10.26719/2016.22.5.343.
Gorla MC, Pinhata JMW, Dias UJ, de Moraes C, Lemos AP. Surveillance of antimicrobial resistance in Neisseria meningitidis strains isolated from invasive cases in Brazil from 2009 to 2016. J Med Microbiol 2018; 67: 750–6. https://doi.org/10.1099/jmm.0.000743.
Hedberg ST, Fredlund H, Nicolas P, Caugant DA, Olcén P, Unemo M. Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives. Antimicrob Agents Chemother 2009; 53: 1561–6. https://doi.org/10.1128/AAC.00994-08.
Harcourt BH, Anderson RD, Wu HM, Cohn AC, Macneil JR, Taylor TH, Population-based surveillance of neisseria meningitidis antimicrobial resistance in the United States. Open Forum Infect Dis 2015; 2(3). https://doi.org/10.1093/ofid/ofv117.
Deghmane A-E, Hong E, Taha M-K. Emergence of meningococci with reduced susceptibility to third-generation cephalosporins. J Antimicrob Chemother 2017; 72: 95–8. https://doi.org/10.1093/jac/dkw400.
Benbachir M, Elmdaghri N, Belabbes H, Haddioui G, Benzaid H, Zaki B. Eleven-year surveillance of antibiotic resistance in Streptococcus pneumoniae in Casablanca (Morocco). Microb Drug Resist 2012; 18: 157–60. https://doi.org/10.1089/mdr.2011.0130.
Benouda A, Ben Redjeb S, Hammami A, Sibille S, Tazir M, Ramdani-Bouguessa N. Antimicrobial resistance of respiratory pathogens in North African countries. J Chemother 2009; 21: 627–32. https://doi.org/10.1179/joc.2009.21.6.627.
Levy C, Varon E, Taha MK, Béchet S, Bonacorsi S, Cohen R, Évolution des méningites bactériennes de l’enfant en France sous l’effet des vaccinations.Change in French bacterial meningitis in children resulting from vaccination. Arch Pediatr 2014; 21: 736–44. https://doi.org/10.1016/j.arcped.2014.04.025.
Fekete S, Szabó D, Tamás L, Polony G. The role of the microbiome in otorhinolaryngology. Orv Hetil 2019; 160: 1533–41. https://doi.org/10.1556/650.2019.31451.
Tefera Z, Mekonnen F, Tiruneh M, Belachew T. Carriage rate of Neisseria meningitidis, antibiotic susceptibility pattern and associated risk factors among primary school children in Gondar town, Northwest Ethiopia. BMC Infect Dis 2020; 20: 358. https://doi.org/10.1186/s12879-020-05080-w.
Tóth Á, Berta B, Tirczka T, Jekkel C, Ábrahám A, Prohászka Z, First description of a rifampicin-resistant Neisseria meningitidis serogroup Y strain causing recurrent invasive meningococcal disease in Hungary. Acta Microbiol Immunol Hung 2017; 64: 1–7. https://doi.org/10.1556/030.64.2017.006.
Karimi H, En-Nanai L, Oudghiri A, Chaoui I, Laglaoui A, Bourkadi JE, Performance of GenoType® MTBDRplus assay in the diagnosis of drug-resistant tuberculosis in Tangier, Morocco. J Glob Antimicrob Resist 2018; 12: 63–7. https://doi.org/10.1016/j.jgar.2017.09.002.
Brik A, Terrade A, Hong E, Deghmane A, Taha MK, Bouafsoun A, Phenotypic and genotypic characterization of meningococcal isolates in Tunis, Tunisia: High diversity and impact on vaccination strategies. Int J Infect Dis IJID Off Publ Int Soc Infect Dis 2020; 91: 73–8. https://doi.org/10.1016/j.ijid.2019.11.013.